BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jiang YA, Zhang YY, Luo HS, Xing SF. Mast cell density and the context of clinicopathological parameters and expression of p185, estrogen receptor, and proliferating cell nuclear antigen in gastric carcinoma. World J Gastroenterol 2002; 8(6): 1005-1008 [PMID: 12439914 DOI: 10.3748/wjg.v8.i6.1005] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 21] [Article Influence: 0.9] [Reference Citation Analysis]
Number Citing Articles
1 Fischer V, Ragipoglu D, Diedrich J, Steppe L, Dudeck A, Schütze K, Kalbitz M, Gebhard F, Haffner-Luntzer M, Ignatius A. Mast Cells Trigger Disturbed Bone Healing in Osteoporotic Mice. J Bone Miner Res 2021. [PMID: 34633111 DOI: 10.1002/jbmr.4455] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
2 Nowak K, Jabłońska E, Ratajczak-Wrona W. NF-κB-An Important Player in Xenoestrogen Signaling in Immune Cells. Cells 2021;10:1799. [PMID: 34359968 DOI: 10.3390/cells10071799] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Ragipoglu D, Dudeck A, Haffner-Luntzer M, Voss M, Kroner J, Ignatius A, Fischer V. The Role of Mast Cells in Bone Metabolism and Bone Disorders. Front Immunol 2020;11:163. [PMID: 32117297 DOI: 10.3389/fimmu.2020.00163] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 13.0] [Reference Citation Analysis]
4 Segovia-Mendoza M, Morales-Montor J. Immune Tumor Microenvironment in Breast Cancer and the Participation of Estrogen and Its Receptors in Cancer Physiopathology. Front Immunol 2019;10:348. [PMID: 30881360 DOI: 10.3389/fimmu.2019.00348] [Cited by in Crossref: 61] [Cited by in F6Publishing: 65] [Article Influence: 20.3] [Reference Citation Analysis]
5 Leporini C, Ammendola M, Marech I, Sammarco G, Sacco R, Gadaleta CD, Oakley C, Russo E, De Sarro G, Ranieri G. Targeting mast cells in gastric cancer with special reference to bone metastases. World J Gastroenterol 2015; 21(37): 10493-10501 [PMID: 26457010 DOI: 10.3748/wjg.v21.i37.10493] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
6 Amoueian S, Attaranzadeh A, Montazer M. Intratumoral CD68-, CD117-, CD56-, and CD1a-positive immune cells and the survival of Iranian patients with non-metastatic intestinal-type gastric carcinoma. Pathology - Research and Practice 2015;211:326-31. [DOI: 10.1016/j.prp.2014.12.013] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
7 Ozdemir O. Any defining role of mast cell or mast cell density in oral squamous cell carcinoma? Ann Med Health Sci Res 2014;4:975-7. [PMID: 25506499 DOI: 10.4103/2141-9248.144931] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
8 Fleischmann A, Schlomm T, Köllermann J, Sekulic N, Huland H, Mirlacher M, Sauter G, Simon R, Erbersdobler A. Immunological microenvironment in prostate cancer: high mast cell densities are associated with favorable tumor characteristics and good prognosis. Prostate 2009;69:976-81. [PMID: 19274666 DOI: 10.1002/pros.20948] [Cited by in Crossref: 95] [Cited by in F6Publishing: 101] [Article Influence: 7.3] [Reference Citation Analysis]
9 Cinel L, Aban M, Basturk M, Ertunc D, Arpacı R, Dilek S, Camdeviren H. The association of mast cell density with myometrial invasion in endometrial carcinoma: A preliminary report. Pathology - Research and Practice 2009;205:255-8. [DOI: 10.1016/j.prp.2008.10.011] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
10 Jensen-Jarolim E, Untersmayr E. Gender-medicine aspects in allergology. Allergy 2008;63:610-5. [PMID: 18394135 DOI: 10.1111/j.1398-9995.2008.01645.x] [Cited by in Crossref: 86] [Cited by in F6Publishing: 90] [Article Influence: 6.1] [Reference Citation Analysis]
11 Winnard KP, Dmitrieva N, Berkley KJ. Cross-organ interactions between reproductive, gastrointestinal, and urinary tracts: modulation by estrous stage and involvement of the hypogastric nerve. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 2006;291:R1592-601. [DOI: 10.1152/ajpregu.00455.2006] [Cited by in Crossref: 84] [Cited by in F6Publishing: 88] [Article Influence: 5.3] [Reference Citation Analysis]
12 Zaitsu M, Narita S, Lambert KC, Grady JJ, Estes DM, Curran EM, Brooks EG, Watson CS, Goldblum RM, Midoro-Horiuti T. Estradiol activates mast cells via a non-genomic estrogen receptor-alpha and calcium influx. Mol Immunol 2007;44:1977-85. [PMID: 17084457 DOI: 10.1016/j.molimm.2006.09.030] [Cited by in Crossref: 163] [Cited by in F6Publishing: 181] [Article Influence: 10.2] [Reference Citation Analysis]
13 Ozdemir O. Can chymase-positive mast cells play a role in the progression of gastric cancer via angiogenesis? J Surg Oncol 2006;94:260-2. [PMID: 16900528 DOI: 10.1002/jso.20570] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
14 Esposito I, Bergmann F, Büchler MW, Friess H. Role of Mast Cells in Pancreatic Carcinoma. Handbook of Immunohistochemistry and in situ Hybridization of Human Carcinomas, Volume 3 - Molecular Genetics, Liver Carcinoma, and Pancreatic Carcinoma 2005. [DOI: 10.1016/s1874-5784(05)80046-7] [Reference Citation Analysis]
15 Wang MC, Yang YM, Li XH, Dong F, Li Y. Maspin expression and its clinicopathological significance in tumorigenesis and progression of gastric cancer. World J Gastroenterol 2004; 10(5): 634-637 [PMID: 14991928 DOI: 10.3748/wjg.v10.i5.634] [Cited by in CrossRef: 35] [Cited by in F6Publishing: 39] [Article Influence: 1.9] [Reference Citation Analysis]
16 Li XH, Zhang WD, Wang BT, Xiao B, Zhang ZS. Gene expression profiling in intestinal-type gastric carcinoma by cDNA microarray. Shijie Huaren Xiaohua Zazhi 2004; 12(1): 16-19 [DOI: 10.11569/wcjd.v12.i1.16] [Reference Citation Analysis]
17 Xie LQ, Yu JP, Luo HS. Expression of estrogen receptor β in human colorectal cancer. World J Gastroenterol 2004; 10(2): 214-217 [PMID: 14716825 DOI: 10.3748/wjg.v10.i2.214] [Cited by in CrossRef: 28] [Cited by in F6Publishing: 30] [Article Influence: 1.6] [Reference Citation Analysis]
18 Yue SQ, Yang YL, Dou KF, Li KZ. Expression of PCNA and CD44mRNA in colorectal cancer with venous invasion and its relationship to liver metastasis. World J Gastroenterol 2003; 9(12): 2863-2865 [PMID: 14669354 DOI: 10.3748/wjg.v9.i12.2863] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 15] [Article Influence: 0.7] [Reference Citation Analysis]
19 Lin WL, Li DG, Chen Q, Lu HM, Ma XM, Sun PL. Clinical efficacy and mechanism of oxaliplatin in treating human gastric carcinoma. Shijie Huaren Xiaohua Zazhi 2003; 11(10): 1535-1539 [DOI: 10.11569/wcjd.v11.i10.1535] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
20 Han ZY, Wu KC, He FT, Han QL, Nie YZ, Han Y, Liu XN, Zheng JY, Xu MH, Lin T, Fan DM. Screening and identification of mimotope of gastric cancer associated antigen MGb1-Ag. World J Gastroenterol 2003; 9(9): 1920-1924 [PMID: 12970876 DOI: 10.3748/wjg.v9.i9.1920] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]